Objective. Our aim was to evaluate whether NLR, LMR, and PLR serve as prognostic biomarkers in AM, the most frequent subtype of cutaneous melanoma (CM) in Peru. Materials and methods. A retrospective study was conducted, including patients diagnosed with AM between 2010 and 2015. Survival analysis was performed using Kaplan-Meier curves and comparisons were made using the log-rank test. Univariate and multivariate survival models were constructed usingCox regression analysis. A p-value less than 0.05 was considered significant. Results. Among our cohort of 135 patients with CM, 51.1% (69 cases) had AM. The median age was 68 years, with a predominance of females (55%), and 88.4% had the plantar site as the primary site. The 5-year overall survival (OS) rate was 54.3%. In the univariate analysis, Clark level III/IV, anaplasia, lymphocytic invasion, stage III-IV, and NLR were associated with poor prognosis. In multivariateanalysis, NLR >3.5 (HR 3.9, 95% CI 1.5-10.3, p=0.005) and Clark level III-IV (HR 3.5, 95% CI 1.6- 7.8, p=0.002) were associated with poor OS. Conclusion. NLR emerges as an independent prognostic factor for OS among Peruvian patients with AM in a single cancer center institution.
No takes yet. Share an insight, caveat, or question.
Maraví et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: